Michael Regan, Equity Research Analyst


What marijuana investors can learn from GameStop trading frenzy

Last week’s meteoric rise of GameStop’s shares made headlines, but what should be made of it? And what can we learn from it for marijuana? What happened with GameStop is a short squeeze. The same thing happened to Tilray in 2018, Volkswagen in 2008 and supermarket operator Piggly Wiggly in the 1920s. While it is possible to […]

Read More

Before election, focus on fundamentals, not emotions, in cannabis investing

Since we last looked at the performance of U.S. and Canadian operators on July 10, publicly traded cannabis companies have seen some interesting stock price trends as candidates running for the top offices in the U.S. take positions on marijuana reform. For a week in October, sentiment improved and cannabis stocks rallied on four words […]

Read More

Tight capital markets – worsened by COVID-19 – derail Schwazze’s cannabis acquisitions

Already struggling capital markets further tightened by the coronavirus, a declining stock price and an improving legalization outlook for cannabis have combined to derail five of the 10 planned deals in Schwazze’s strategy to consolidate the Colorado market. While COVID-19 actually has improved the long-term investment case for the marijuana industry after state governments deemed […]

Read More